BeiGene Corp - Proyeksi bathi mangsa ngarep ONC

Logo perusahaan publik BeiGene Ltd (ONC)

BeiGene Ltd (ONC) outsources its anti-tumor drug testing to external CRO partners in strict compliance with regulations. This chart reflects profits at 1.11, while the business resists expansion by global pharmaceutical behemoths. A technological edge is driven by the success of Brukinsa and accessible research in China, which strengthens the firm's market position.

ONC - Proyeksi bathi mangsa ngarep BeiGene Ltd ing rentang 27.02.2025 - 17.11.2026

Rincian metrik lan analitis perusahaan BeiGene Corp (ONC)

- kuotasi lan prakiraan analis:
Ringkesan analisis perusahaan:BeiGene Oncology, ONC
Produk dadi BeiGene Ltd.

Defensive assets are selected based on their ability to generate stable cash flow, which for BeiGene Ltd (ONC) is ensured by unique patents and large-scale investments in oncology research. The consensus net income per share forecast, reflected in the forward earnings trend, allows for an assessment of the business's fundamental value while accounting for regulatory risks in China and the US and filtering out short-term market noise.

Pesaing BeiGene Ltd

Bathi sing dikarepake Halozyme|RVMD: Penghasilan resik sing dikarepake|Bathi mangsa ngarep AAPG (Ascentage)|CGON (CG Oncology Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep URGN (urogen.com)|BCAX - Bathi mangsa ngarep|PSNL: Bathi mangsa ngarep|ERAS - Proyeksi bathi mangsa ngarep|Delcath (DCTH) - Bathi sing dikarepake|YmAbs - Penghasilan resik sing dikarepake|AURA (Aura Biosciences Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Candel Therapeutics CADL|Proyeksi bathi mangsa ngarep ARAY|SLS - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ACTU (Actuate Therapeutics Inc)|Prakiraan bathi perusahaan Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Protara Therapeutics, Inc.|FATE: Proyeksi bathi mangsa ngarep|WHWK - Prakiraan bathi perusahaan|Bathi sing dikarepake TScan Therapeutics, Inc.|Champions Oncology - Bathi forward|Proyeksi bathi mangsa ngarep XBIT|Prakiraan bathi perusahaan CEL-SCI Corp|Bathi sing dikarepake OS Therapies OSTX|Penghasilan resik sing dikarepake RADX|artivabio.com - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake